New 'Find and Treat' drugs target brain tumors in advanced cancer
NCT ID NCT07178938
Summary
This study is testing a new type of 'theranostic' drug that first acts like a medical dye to locate cancer in the brain and then delivers targeted radiation to treat it. It is for adults with solid tumors, including HER2-positive breast cancer, that have spread to the brain and are still growing. The main goal is to see if these drugs can effectively shrink brain tumors and to check how safe they are.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.